- Home
- ATXG vs TCRT Comparison
ATXG vs TCRT Comparison
Compare ATXG & TCRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATXG
- TCRT
- Stock Information
- Founded
- ATXG 2014
- TCRT 1998
- Country
- ATXG China
- TCRT United States
- Employees
- ATXG N/A
- TCRT N/A
- Industry
- ATXG Professional Services
- TCRT Biotechnology: Pharmaceutical Preparations
- Sector
- ATXG Consumer Discretionary
- TCRT Health Care
- Exchange
- ATXG Nasdaq
- TCRT Nasdaq
- Market Cap
- ATXG 4.0M
- TCRT 3.8M
- IPO Year
- ATXG N/A
- TCRT N/A
- Fundamental
- Price
- ATXG $0.63
- TCRT $5.02
- Analyst Decision
- ATXG
- TCRT
- Analyst Count
- ATXG 0
- TCRT 0
- Target Price
- ATXG N/A
- TCRT N/A
- AVG Volume (30 Days)
- ATXG 2.4M
- TCRT 48.5K
- Earning Date
- ATXG 08-13-2025
- TCRT 08-13-2025
- Dividend Yield
- ATXG N/A
- TCRT N/A
- EPS Growth
- ATXG N/A
- TCRT N/A
- EPS
- ATXG N/A
- TCRT N/A
- Revenue
- ATXG $4,180,913.00
- TCRT $11,000.00
- Revenue This Year
- ATXG N/A
- TCRT $5,680,500.00
- Revenue Next Year
- ATXG N/A
- TCRT N/A
- P/E Ratio
- ATXG N/A
- TCRT N/A
- Revenue Growth
- ATXG N/A
- TCRT 83.33
- 52 Week Low
- ATXG $0.49
- TCRT $1.31
- 52 Week High
- ATXG $1.86
- TCRT $6.99
- Technical
- Relative Strength Index (RSI)
- ATXG 45.97
- TCRT 69.35
- Support Level
- ATXG $0.56
- TCRT $4.72
- Resistance Level
- ATXG $0.65
- TCRT $5.24
- Average True Range (ATR)
- ATXG 0.10
- TCRT 0.52
- MACD
- ATXG -0.00
- TCRT 0.02
- Stochastic Oscillator
- ATXG 18.65
- TCRT 84.68
About ATXG Addentax Group Corp.
Addentax Group Corp is an investment holding company. The company through its operating subsidiaries functions in the following segments; Garment manufacturing; Logistics services; Property management and subleasing. It generates maximum revenue from the Logistics services segment which provides logistics services including storage, transportation, warehousing, handling, packaging, and order processing. It also provides customs declaration and tax clearance services to its customers who export goods overseas. Geographically, the company derives all of its revenue from China.
About TCRT Alaunos Therapeutics Inc.
Alaunos Therapeutics Inc is a clinical-stage cellular immuno-oncology company dedicated to the treatment of solid tumors through adoptive TCR-T cell therapy. It strikes cancer at its core by engineering cell therapies that target Neoantigens arising from genomic mutations. It has a single reportable and operating segment related to biopharmaceutical research and development.